Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
USE CASES
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
PatSnap Eureka Desktop
NEWAnalytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesPlateforme ouverte
NEWServices professionnels
Cabinets d'avocats
Sciences de la vie
Haute technologie
Competitor Tech Research
Design Risk Screening
Cosmetic Formulation
Telecom SEP Claim Chart
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport Beyond BCMA: how GPRC5D, FcRH5, trispecific antibodies, and CAR-T plus bispecific combinations are reshaping the multiple myeloma treatment pipeline.
Article | Rapport How sclerostin inhibitors, activin receptor antagonists, and WNT pathway agents are reshaping the osteoporosis pipeline. IP signals, clinical data, and strategic implications.
Article | Rapport How third-generation EGFR TKI combinations—CDK4/6, RAF inhibitors, ADCs, and bispecifics—are tackling acquired resistance in EGFR-mutant NSCLC. Patent pipeline analysis.
Article | Rapport Sotatercept, ralinepag, and triple combination regimens are reshaping the PAH drug pipeline. Explore patent signals, clinical data, and emerging mechanistic strategies.
Article | Rapport Explore the IPF drug pipeline: LPA1 antagonists, PDE4B inhibitors, anti-OSMRβ biologics, and antifibrotic combination strategies reshaping pulmonary fibrosis treatment.
Article | Rapport Explore the 2026 bone conduction audio technology patent landscape: key innovators, emerging directions, and strategic IP white space across wearables, XR, and hearing health.
Article | Rapport How do edge AI inference and federated learning differ in industrial IoT? A patent-based analysis of 55+ filings reveals key architectural, latency, and privacy distinctions.
Article | Rapport How do edge AI inference and federated learning differ in industrial IoT? A patent-based technical analysis of architectures, latency, privacy, and hybrid convergence.
Article | Rapport A 2026 patent landscape of CSP receiver technology: cavity receivers, molten salt tube arrays, sodium HTF, thermomechanical monitoring, and emerging modular designs.
Article | Rapport Silicon anode batteries offer 3,400–4,200 mAh/g capacity — 10× graphite. Explore the 2026 patent landscape, key assignees, and emerging manufacturing trends.
Article | Rapport What causes capacity imbalance in large-format battery modules, and how do BMS algorithms correct it? A technical deep-dive drawing on 60+ patents from LG, Samsung, Bosch and more.
Article | Rapport Explore the 2026 SAR technology landscape: bistatic architectures, AI-assisted imaging, GEO satellites, and autonomous mission planning across 74 patent records.
Article | Rapport Why do large-format battery modules lose usable capacity over time? Discover the root causes of cell imbalance and the BMS algorithms correcting it—backed by 60+ patents.
Article | Rapport Neuroprotective peptides, photobiomodulation, and cell therapy approaches reshaping the geographic atrophy drug pipeline beyond complement inhibitors. Patent analysis inside.
Article | Rapport SAR technology in 2026: bistatic architectures, AI-assisted imaging, GEO satellites, and autonomous mission planning. Patent landscape analysis from 74 records.